JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.13% |
| 2 | Financials | 11.98% |
| 3 | Healthcare | 9.78% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4601
Clarus
CLAR
$144M
| $132K | ﹤0.01% |
10,358
+4,993
| +93% | +$56.3K |
|
4602
LeMaitre Vascular
LMAT
$1.88B
| $132K | ﹤0.01% |
4,264
+185
| +5% | +$4.94K |
|
|
SRNE
4603
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $132K | ﹤0.01% |
27,819
-106
| -0.4% | -$278 |
|
|
AKCA
4604
DELISTED
Akcea Therapeutics Inc
AKCA
| $132K | ﹤0.01% |
4,625
-28
| -0.6% | -$816 |
|
4605
Core Molding Technologies
CMT
$231M
| $131K | ﹤0.01% |
17,705
-11,412
| -39% | -$90.4K |
|
4606
Ezcorp Inc
EZPW
$1.8B
| $131K | ﹤0.01% |
13,977
-2,570
| -16% | -$24.2K |
|
4607
NRC Health Common Stock
NRC
$460M
| $131K | ﹤0.01% |
3,388
-484
| -13% | -$19K |
|
4608
Talos Energy
TALO
$2.56B
| $131K | ﹤0.01% |
4,916
-232
| -5% | -$5.03K |
|
4609
Vanguard Tax-Exempt Bond Index Fund
VTEB
$46.1B
| $131K | ﹤0.01% |
2,521
-76,240
| -97% | -$3.92M |
|
|
SFE
4610
DELISTED
Safeguard Scientifics, Inc.
SFE
| $131K | ﹤0.01% |
12,052
+6,525
| +118% | +$66.2K |
|
|
FCRD
4611
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
| $130K | ﹤0.01% |
19,775
-3,007
| -13% | -$20.2K |
|
|
PYX
4612
DELISTED
Pyxus International, Inc.
PYX
| $130K | ﹤0.01% |
5,446
+3,303
| +154% | +$68.9K |
|
4613
Seaboard Corp
SEB
$4.02B
| $129K | ﹤0.01% |
30
-7
| -19% | -$27K |
|
4614
Village Super Market
VLGEA
$635M
| $129K | ﹤0.01% |
4,721
-5,158
| -52% | -$146K |
|
|
CO
4615
DELISTED
Global Cord Blood Corporation
CO
| $129K | ﹤0.01% |
18,417
+18,194
| +8,159% | +$120K |
|
4616
BCB Bancorp
BCBP
$163M
| $128K | ﹤0.01% |
9,576
-3,059
| -24% | -$37.1K |
|
4617
United States Brent Oil Fund
BNO
$771M
| $127K | ﹤0.01% |
6,622
+672
| +11% | +$12.1K |
|
4618
Orrstown Financial Services
ORRF
$851M
| $127K | ﹤0.01% |
6,843
+1,853
| +37% | +$36.3K |
|
4619
CALL
Energous
WATT
$86.4M
| $127K | ﹤0.01% |
+33
| New | +$143K |
|
|
ARQL
4620
DELISTED
Arqule Inc
ARQL
| $127K | ﹤0.01% |
26,455
-1,243
| -4% | -$4.8K |
|
4621
Collegium Pharmaceutical
COLL
$919M
| $126K | ﹤0.01% |
8,346
-2,501
| -23% | -$40.1K |
|
|
FFWM
4622
DELISTED
First Foundation Inc
FFWM
| $126K | ﹤0.01% |
9,295
-437
| -4% | -$6.32K |
|
4623
MediciNova
MNOV
$64.5M
| $126K | ﹤0.01% |
15,101
+4,844
| +47% | +$42.2K |
|
4624
Yeti Holdings
YETI
$3.37B
| $126K | ﹤0.01% |
4,166
-296,446
| -99% | -$6.45M |
|
|
ARC
4625
DELISTED
ARC Document Solutions, Inc.
ARC
| $126K | ﹤0.01% |
56,557
-161,781
| -74% | -$394K |
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,671 reduced and 538 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 538 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.